Company Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 19:20:00 13/02/2026 +03			5-day change	1st Jan Change
310.60 ^DKK	+1.32%		+5.11%	-4.50%

02-13	Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows	RE
02-13	Novo Nordisk's Wegovy Tablet Reaches 38,000 New Prescriptions in the US	FW

Business description: Novo Nordisk A/S

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- diabetes and obesity treatment products (93.7%);

- rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.

Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).

Number of employees: 69,150

Sales by Activity: Novo Nordisk A/S

Fiscal Period: December	2021 (DKK)	2022 (DKK)	2023 (DKK)	2024 (DKK)	2025 (DKK)
Diabetes and Obesity Care	122B	156B	215B	272B	289B
Rare Disease	19.2B	20.54B	17.16B	18.64B	19.61B

See all business segments

Geographical breakdown of sales: Novo Nordisk A/S

Fiscal Period: December	2021 (DKK)	2022 (DKK)	2023 (DKK)	2024 (DKK)	2025 (DKK)
United States of America (USA)	63.01B	84.66B	128B	167B	173B
Europe and Canada	-	-	-	-	66.09B
Emerging Markets	-	-	-	-	30.44B
APAC	-	-	-	-	20.71B
Region China	16.02B	16.21B	16.69B	18.5B	18.66B
EMEA	37.71B	44.24B	50.87B	60.4B	-
North America (Excl. US)	4.25B	6.45B	9.1B	10.77B	-
Rest of the World	19.81B	25.4B	28.08B	33.33B	-

See all geographic segments

Executive Committee: Novo Nordisk A/S

Manager	Title	Age	Since
Maziar Mike Doustdar CEO	Chief Executive Officer	56	07/08/2025
Karsten Munk Knudsen DFI	Director of Finance/CFO	55	15/02/2018
Martin Lange CTO	Chief Tech/Sci/R&D Officer	56	07/08/2025
Liselotte Hyveled PRN	Corporate Officer/Principal	60	-
Tania Sabroe HRO	Human Resources Officer	49	01/01/2022

See NOVO NORDISK A/S governance

Composition of the Board of Directors: Novo Nordisk A/S

Director	Title	Age	Since
Kasim Kutay BRD	Director/Board Member	61	23/03/2017
Mette Bøjer Jensen BRD	Director/Board Member	51	22/03/2018
Elisabeth Christensen BRD	Director/Board Member	61	24/03/2022
Liselotte Hyveled BRD	Director/Board Member	60	01/03/2014
Lars Rebien Sørensen CHM	Chairman	71	14/11/2025
Cees de Jong BRD	Director/Board Member	64	14/11/2025
Britt Meelby Jensen BRD	Director/Board Member	53	14/11/2025
Stephan Engels BRD	Director/Board Member	63	14/11/2025
Tanja Villumsen BRD	Director/Board Member	-	31/01/2026

Composition of the Board of Directors

Shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	177,560,500	5.238 %	10 453 M kr
NOVO NORDISK A/S 0.5393 %	18,283,326	0.5393 %	1 076 M kr
Nykredit Bank A/S (Investment Management) 0.1474 %	4,997,158	0.1474 %	294 M kr
Nordea Investment Management AB 0.1399 %	4,741,771	0.1399 %	279 M kr
Sjunde AP-fonden 0.1398 %	4,738,475	0.1398 %	279 M kr

Name	Equities	%	Valuation
Caixa DTVM SA 0.000011 %	2,970	0.000011 %	22 294 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,074,872,000	100 %	63 280 M kr
ANIMA Sgr SpA 0.0108 %	115,783	0.0108 %	7 M kr
Russell Investments Ltd. 0.000038 %	405	0.000038 %	23 843 kr

Name	Equities	%	Valuation
Loomis, Sayles & Co. LP 0.5054 %	17,135,384	0.5054 %	1 018 M kr
Fiduciary Trust Company International 0.4337 %	14,702,508	0.4337 %	874 M kr
Fidelity Management & Research Co. LLC 0.4152 %	14,075,391	0.4152 %	837 M kr
Merrill Lynch International 0.3954 %	13,403,378	0.3954 %	797 M kr
Eaton Vance Management 0.3788 %	12,842,089	0.3788 %	763 M kr

List of NOVO NORDISK A/S shareholders

Holdings: Novo Nordisk A/S

Name	Equities	%	Valuation
NOVO NORDISK A/S 0.54%	18,283,326	0.54%	1 076 M $
NNIT A/S 17.5%	4,375,000	17.5%	32 M $
INNATE PHARMA 9.49%	8,895,649	9.49%	16 M $

Company details: Novo Nordisk A/S

Novo Nordisk A/S

Novo Allé 1

2880, Bagsværd

+45 44 44 88 88

http://www.novonordisk.com

Group companies: Novo Nordisk A/S

Name	Category and Sector
Novo Nordisk Service Centre (India) Pvt Ltd. Novo Nordisk Service Centre (India) Pvt Ltd. Part of Novo Nordisk A/S, Novo Nordisk Service Centre (India) Pvt Ltd. is a company based in Bangalore, India. The company was founded in 2011.
Novo Nordisk Service Centre (India) Pvt Ltd. Novo Nordisk Service Centre (India) Pvt Ltd. Part of Novo Nordisk A/S, Novo Nordisk Service Centre (India) Pvt Ltd. is a company based in Bangalore, India. The company was founded in 2011.
NNE A/S NNE A/S Engineering & ConstructionIndustrial Services Supplies systems, consultancy and engineering services	Engineering & Construction
NNE A/S NNE A/S Engineering & ConstructionIndustrial Services Supplies systems, consultancy and engineering services	Engineering & Construction
Novo Nordisk Health Care AG Novo Nordisk Health Care AG Develops, manufactures, markets and distributes pharmaceutical products

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
NOVO NORDISK A/S	+1.32%	+5.11%	-44.29%	-37.51%	219B
ELI LILLY AND COMPANY	+0.33%	-1.72%	+23.18%	+199.23%	929B
JOHNSON & JOHNSON	-0.45%	+1.44%	+55.91%	+50.24%	587B
ABBVIE INC.	+1.76%	+3.61%	+20.03%	+51.71%	409B
ROCHE HOLDING AG	+0.08%	+1.01%	+22.24%	+29.31%	374B
ASTRAZENECA PLC	+1.42%	+7.19%	+29.13%	+31.26%	320B
NOVARTIS AG	+1.08%	+4.32%	+31.22%	+55.61%	311B
MERCK & CO., INC.	+1.82%	-0.43%	+46.26%	+11.65%	301B
AMGEN INC.	+1.52%	-3.94%	+26.80%	+53.17%	199B
GILEAD SCIENCES, INC.	+2.09%	+1.63%	+48.90%	+80.88%	192B
Average	+1.10%	+1.96%	+25.94%	+52.56%	384.1B
Weighted average by Cap.	+0.81%	+1.58%	+28.33%	+76.90%